Rhodes Sophie J, Sarfas Charlotte, Knight Gwenan M, White Andrew, Pathan Ansar A, McShane Helen, Evans Thomas G, Fletcher Helen, Sharpe Sally, White Richard G
TB Modelling Group, CMMID, TB Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom
Public Health England, Porton Down, United Kingdom.
Clin Vaccine Immunol. 2017 Mar 6;24(3). doi: 10.1128/CVI.00525-16. Print 2017 Mar.
Macaques play a central role in the development of human tuberculosis (TB) vaccines. Immune and challenge responses differ across macaque and human subpopulations. We used novel immunostimulation/immunodynamic modeling methods in a proof-of-concept study to determine which macaque subpopulations best predicted immune responses in different human subpopulations. Data on gamma interferon (IFN-γ)-secreting CD4 T cells over time after recent BCG vaccination were available for 55 humans and 81 macaques. Human population covariates were baseline BCG vaccination status, time since BCG vaccination, gender, and the monocyte/lymphocyte cell count ratio. The macaque population covariate was the colony of origin. A two-compartment mathematical model describing the dynamics of the IFN-γ T cell response after BCG vaccination was calibrated to these data using nonlinear mixed-effects methods. The model was calibrated to macaque and human data separately. The association between subpopulations and the BCG immune response in each species was assessed. The macaque subpopulations that best predicted immune responses in different human subpopulations were identified using Bayesian information criteria. We found that the macaque colony and the human baseline BCG status were significantly ( < 0.05) associated with the BCG-induced immune response. For humans who were BCG naïve at baseline, Indonesian cynomolgus macaques and Indian rhesus macaques best predicted the immune response. For humans who had already been BCG vaccinated at baseline, Mauritian cynomolgus macaques best predicted the immune response. This work suggests that the immune responses of different human populations may be best modeled by different macaque colonies, and it demonstrates the potential utility of immunostimulation/immunodynamic modeling to accelerate TB vaccine development.
猕猴在人类结核病(TB)疫苗的研发中起着核心作用。猕猴和人类亚群的免疫及激发反应存在差异。在一项概念验证研究中,我们使用了新型免疫刺激/免疫动力学建模方法,以确定哪些猕猴亚群能最好地预测不同人类亚群的免疫反应。近期卡介苗接种后不同时间点分泌γ干扰素(IFN-γ)的CD4 T细胞的数据可用于55名人类和81只猕猴。人类群体协变量包括基线卡介苗接种状态、卡介苗接种后的时间、性别以及单核细胞/淋巴细胞计数比值。猕猴群体协变量是来源菌落。使用非线性混合效应方法,将描述卡介苗接种后IFN-γ T细胞反应动力学的两室数学模型校准到这些数据。该模型分别校准到猕猴和人类数据。评估了每个物种中亚群与卡介苗免疫反应之间的关联。使用贝叶斯信息准则确定了能最好地预测不同人类亚群免疫反应的猕猴亚群。我们发现,猕猴菌落和人类基线卡介苗状态与卡介苗诱导的免疫反应显著相关(<0.05)。对于基线时未接种卡介苗的人类,印度尼西亚食蟹猕猴和印度恒河猴能最好地预测免疫反应。对于基线时已接种卡介苗的人类,毛里求斯食蟹猕猴能最好地预测免疫反应。这项工作表明,不同人类群体的免疫反应可能最好由不同的猕猴菌落来建模,并且它证明了免疫刺激/免疫动力学建模在加速结核病疫苗研发方面的潜在效用。